C
CORCEPT THERAPEUTICS INCORPORATED
NASDAQ: CORT (Corcept Therapeutics Incorporat)
Last update: 32 minutes ago72.77
1.14 (1.59%)
| Previous Close | 71.63 |
| Volume | 1,406,677 |
| Price / Earnings (Forward) | 14.80 |
| Price / Sales | 9.83 |
| Price / Book | 10.39 |
| 52 Weeks Range |
| Profit Margin | 19.55% |
| Operating Margin (TTM) | 2.17% |
| Diluted EPS (TTM) | 1.15 |
| Quarterly Revenue Growth (YOY) | 7.10% |
| Quarterly Earnings Growth (YOY) | -26.00% |
| Total Debt/Equity (MRQ) | 1.00% |
| Current Ratio (MRQ) | 3.07 |
| Operating Cash Flow (TTM) | 179.44 M |
| Levered Free Cash Flow (TTM) | 160.08 M |
| Return on Assets (TTM) | 9.18% |
| Return on Equity (TTM) | 21.77% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Corcept Therapeutics Incorporat | Mixed | Bearish |
AIStockmoo Score
| Value 35% | 0.6 |
| AI Insight info | NA |
| Relative Valuation info | -1.9 |
| Financial Health info | 4.4 |
| Timing 35% | -1.7 |
| AI Technical info | NA |
| Technical Oscillators info | -0.5 |
| Technical Moving Averages info | -3.5 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | 0.0 |
| Environment | ×1.21 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | -36.3% |
| Pillar Agreement | ×0.98 |
| Not in score | |
| Price Volatility info | 2.1 |
| Final Score | -0.45 |
Select this tab to load the latest available analysis.
|
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 11.49% |
| % Held by Institutions | 80.05% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Ingalls & Snyder Llc | 30 Jun 2026 | 7,934,507 |
| Vanguard Portfolio Management Llc | 30 Jun 2026 | 5,044,638 |
| Parallel Advisors, Llc | 30 Sep 2026 | 3,902,544 |
| Fmr Llc | 30 Jun 2026 | 3,337,618 |
| Aqr Capital Management Llc | 30 Jun 2026 | 2,582,561 |
| First Trust Advisors Lp | 30 Jun 2026 | 1,829,545 |
| Tang Capital Management Llc | 30 Jun 2026 | 1,500,000 |
| Charles Schwab Investment Management Inc | 30 Jun 2026 | 1,157,580 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| MADUCK SEAN | - | 81.23 | -25,000 | -2,030,844 |
| VIEIRA ROBERTO WANDENKOLK | - | 80.46 | -8,333 | -670,473 |
| Aggregate Net Quantity | -33,333 | |||
| Aggregate Net Value ($) | -2,701,317 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 81.04 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MADUCK SEAN | 03 Nov 2026 | Automatic sell (-) | 13,159 | 81.93 | 1,078,117 | |
| MADUCK SEAN | 03 Nov 2026 | Option execute | 13,159 | - | - | |
| VIEIRA ROBERTO WANDENKOLK | Officer | 02 Nov 2026 | Automatic sell (-) | 8,333 | 80.46 | 670,473 |
| VIEIRA ROBERTO WANDENKOLK | Officer | 02 Nov 2026 | Option execute | 8,333 | - | - |
| MADUCK SEAN | 02 Nov 2026 | Automatic sell (-) | 11,841 | 80.46 | 952,727 | |
| MADUCK SEAN | 02 Nov 2026 | Option execute | 11,841 | - | - |
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |